Cite
Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation.
MLA
Zhang, Meng, et al. “Pyruvate Dehydrogenase Kinase 1 Contributes to Cisplatin Resistance of Ovarian Cancer through EGFR Activation.” Journal of Cellular Physiology, vol. 234, no. 5, May 2019, pp. 6361–70. EBSCOhost, https://doi.org/10.1002/jcp.27369.
APA
Zhang, M., Cong, Q., Zhang, X., Zhang, M., Lu, Y., & Xu, C. (2019). Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation. Journal of Cellular Physiology, 234(5), 6361–6370. https://doi.org/10.1002/jcp.27369
Chicago
Zhang, Meng, Qing Cong, Xiao‐Yan Zhang, Ming‐Xing Zhang, Ying‐Ying Lu, and Cong‐Jian Xu. 2019. “Pyruvate Dehydrogenase Kinase 1 Contributes to Cisplatin Resistance of Ovarian Cancer through EGFR Activation.” Journal of Cellular Physiology 234 (5): 6361–70. doi:10.1002/jcp.27369.